Khalili S, Mohseninia A, Liu C, Banister C, Heine P, Khazan M
Commun Biol. 2025; 8(1):436.
PMID: 40082551
PMC: 11906589.
DOI: 10.1038/s42003-025-07822-5.
Sibony-Benyamini H, Jbara R, Shubash Napso T, Abu-Rahmoun L, Vizenblit D, Easton-Mor M
Genome Med. 2025; 17(1):14.
PMID: 39994739
PMC: 11853333.
DOI: 10.1186/s13073-025-01439-3.
Noto A, Valenzisi P, Di Feo F, Fratini F, Kulikowicz T, Sommers J
Nat Commun. 2025; 16(1):997.
PMID: 39870632
PMC: 11772831.
DOI: 10.1038/s41467-025-55958-z.
McGinty R, Balick D, Mirkin S, Sunyaev S
bioRxiv. 2025; .
PMID: 39829886
PMC: 11741425.
DOI: 10.1101/2025.01.09.631797.
Lu M, Wu J, Gao Q, Jin R, An C, Ma T
Genes Dis. 2025; 12(2):101219.
PMID: 39759116
PMC: 11697192.
DOI: 10.1016/j.gendis.2024.101219.
Downstream transcription promotes human recurrent CNV associated AT-rich sequence mediated genome rearrangements in yeast.
Xie F, Zhang X, Chen J, Xu X, Li S, Xia T
iScience. 2025; 27(12):111508.
PMID: 39758996
PMC: 11697705.
DOI: 10.1016/j.isci.2024.111508.
DNA polymerase zeta can efficiently replicate structures formed by AT/TA repeat sequences and prevent their deletion.
Das M, Hile S, Brewster J, Boer J, Bezalel-Buch R, Guo Q
Nucleic Acids Res. 2024; 53(3).
PMID: 39727171
PMC: 11797062.
DOI: 10.1093/nar/gkae1254.
Application and research progress of synthetic lethality in the development of anticancer therapeutic drugs.
Gong X, Liu C, Tang H, Wu S, Yang Q
Front Oncol. 2024; 14:1460412.
PMID: 39655075
PMC: 11625670.
DOI: 10.3389/fonc.2024.1460412.
Polymorphic potential of SRF binding site of gene promoter: study.
Profantova B, rimal V, Profant V, Socha O, Barvik I, Stepankova H
RSC Adv. 2024; 14(51):38253-38267.
PMID: 39628460
PMC: 11613138.
DOI: 10.1039/d4ra05897f.
Synthetic lethal strategies for the development of cancer therapeutics.
Ngoi N, Gallo D, Torrado C, Nardo M, Durocher D, Yap T
Nat Rev Clin Oncol. 2024; 22(1):46-64.
PMID: 39627502
DOI: 10.1038/s41571-024-00966-z.
Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities.
Takemon Y, Pleasance E, Gagliardi A, Hughes C, Csizmok V, Wee K
Genome Med. 2024; 16(1):136.
PMID: 39578878
PMC: 11583415.
DOI: 10.1186/s13073-024-01401-9.
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.
Drew Y, Zenke F, Curtin N
Nat Rev Drug Discov. 2024; 24(1):19-39.
PMID: 39533099
DOI: 10.1038/s41573-024-01060-w.
Towards the genomic sequence code of DNA fragility for machine learning.
Pflughaupt P, Abdullah A, Masuda K, Sahakyan A
Nucleic Acids Res. 2024; 52(21):12798-12816.
PMID: 39441076
PMC: 11602142.
DOI: 10.1093/nar/gkae914.
Werner syndrome RECQ helicase participates in and directs maintenance of the protein complexes of constitutive heterochromatin in proliferating human cells.
Lazarchuk P, Nguyen M, Curca C, Pavlova M, Oshima J, Sidorova J
Aging (Albany NY). 2024; 16(20):12977-13011.
PMID: 39422615
PMC: 11552638.
DOI: 10.18632/aging.206132.
Microsatellite density landscapes illustrate short tandem repeats aggregation in the complete reference human genome.
Xia Y, Li D, Chen T, Pan S, Huang H, Zhang W
BMC Genomics. 2024; 25(1):960.
PMID: 39402450
PMC: 11477012.
DOI: 10.1186/s12864-024-10843-9.
DNA damage response in breast cancer and its significant role in guiding novel precise therapies.
Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H
Biomark Res. 2024; 12(1):111.
PMID: 39334297
PMC: 11437670.
DOI: 10.1186/s40364-024-00653-2.
Ligand discovery by activity-based protein profiling.
Niphakis M, Cravatt B
Cell Chem Biol. 2024; 31(9):1636-1651.
PMID: 39303700
PMC: 11662599.
DOI: 10.1016/j.chembiol.2024.08.006.
USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication.
Mackay H, Stone H, Ronson G, Ellis K, Lanz A, Aghabi Y
Nat Commun. 2024; 15(1):8102.
PMID: 39284827
PMC: 11405836.
DOI: 10.1038/s41467-024-52250-4.
PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability.
Tejwani V, Carroll T, Macartney T, Bandau S, Alabert C, Saredi G
Sci Rep. 2024; 14(1):20824.
PMID: 39242638
PMC: 11379953.
DOI: 10.1038/s41598-024-71160-5.
Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA.
Xu H, Ye J, Zhang K, Hu Q, Cui T, Tong C
Nat Chem. 2024; 16(11):1811-1821.
PMID: 39223307
DOI: 10.1038/s41557-024-01609-7.